APP and Alzheimer disease: Evidence has been provided that pathological cell models release EVs containing molecules that are the main pathological hallmarks of either AD, i.e., Aβ peptide [68], APP fragments [69,70] and Tau [71], or PD, i.e., α-synuclein [72].